熱門資訊> 正文
Sangamo Therapeutics首席财务官退休
2025-09-12 21:03
- Shares of Sangamo Therapeutics (NASDAQ:SGMO) fell on Friday after the company's chief financial officer, Prathyusha Duraibabu, notified of her decision to resign, effective October 1.
- The resignation decision is in order to assume a senior leadership role with a privately-held artificial intelligence company, Sangamo said in a filing.
- On October 1, Duraibabu will transition to part-time employment, following which she will continue to serve as principal financial officer on an interim basis till a successor is named.
- The stock of the company is down 4% premarket.
More on Sangamo Therapeutics
- Sangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call Transcript
- Sangamo Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Sangamo Therapeutics Q2 2025 Earnings Preview
- Sangamo rises after trial data for Fabry disease therapy
- Seeking Alpha’s Quant Rating on Sangamo Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
